Bora Biologics, a leading contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, announced a major expansion of its U.S. FDA-registered commercial ...

Bora Biologics, a contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, is ...

Samsung Biologics, the biotech arm of Samsung, said Monday that its contract manufacturing organization (CMO) deals have ...

Trump signed an Executive Order (EO) titled “Regulatory Relief Critical Medicines.” The order’s goal is to strengthen the U.S. pharmaceutical supply chain by streamlining regulatory processes, ...

Samsung Biologics Co., the biotech arm of South Korea's Samsung Group, said Monday that its contract manufacturing ...

Robotic systems are becoming integral to modern biopharmaceutical manufacturing facilities. Advanced robotic arms and automated systems handle various tasks, including vial filling, packaging and ...

It will be one of the largest contract biopharmaceutical manufacturing facilities in North America, according to the town’s economic development group. The company has invested $3.2 billion in ...

Shamekh SIV Solutions, LLC announced their $5.8 billion global plan for a series of pharmaceutical manufacturing facilities aligned with the executive order signed by President Trump on May 5, 2025, ...

Greentech and Roche are planning domestic manufacturing facilities, adding to the list of projects sparked by Trump's push ...

Work on the new Singapore facility has been underway since ... Adding that back then Singapore's biopharmaceutical manufacturing was "in its infancy", he pointed to the dramatic changes that ...

Swiss pharmaceutical giant Roche announced today that it plans to invest 2.04 billion yuan (about $283M) in building a new biopharmaceutical manufacturing plant in Shanghai's Pudong district. The ...